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ABSTRACT  27 
The intermittent energy restriction (IER) approach to weight-loss involves short periods of 28 
substantial (>70%) energy restriction interspersed with normal eating. Studies to date 29 
comparing IER to continuous energy restriction (CER) have predominantly measured fasting 30 
indices of cardiometabolic risk. This study aimed to compare the effects of IER and CER on 31 
postprandial glucose and lipid metabolism following matched weight-loss. 27 (13 male) 32 
overweight/obese participants (46±3y, 30.1±1.0kg/m2) were randomised to either an IER 33 
(2638 kJ for two days/week with an overall ER of 22±0.3%, n=15) or CER (2510kJ below 34 
requirements with overall ER of 23±0.8%) intervention. Six-hour postprandial responses to a 35 
test meal and changes in anthropometry (fat mass, fat-free mass, circumferences) were 36 
assessed at baseline and upon attainment of 5% weight-loss, following a 7 day period of 37 
weight stabilisation. The study found no significant difference in the time to attain a 5% 38 
weight loss between groups (median 59 [41-70] days and 73 [48-128] days respectively, 39 
p=0.246), or in body composition (p≥0.430). For postprandial measures, neither diet 40 
significantly altered glycaemia (p=0.226), whereas insulinaemia was reduced comparatively 41 
(p=0.903). The reduction in c-peptide tended (p=0.057) to be greater following IER 42 
(309128±23268 to 247781±20709 pmol.360min.L-1) versus CER (297204±25112 to 43 
301655±32714 pmol.360min.L-1). The relative reduction in triacylglycerol responses was 44 
greater (p=0.045) following IER (106±30 to 68±15 mmol.360min.L-1) compared to CER 45 
(117±43 to 130±31 mmol.360min.L-1). In conclusion, these preliminary findings highlight 46 
underlying differences between IER and CER, including a superiority of IER in reducing 47 
postprandial lipaemia, which now warrant targeted mechanistic evaluation within larger study 48 
cohorts.    49 
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Introduction  50 
The development of overweight/obesity is closely associated with numerous inter-related 51 
metabolic complications including insulin resistance and dyslipidaemia. These in turn 52 
increase an individual’s risk of type 2 diabetes and cardiovascular disease (CVD), prevalence 53 
rates of which are rising in congruence with weight trends (1). Glucose and lipid homeostasis 54 
can be improved through weight-loss (2) which is most commonly advised via a modest 55 
(daily) continuous energy restriction (CER) (3). Intermittent energy restriction (IER) has 56 
received considerable recent interest as an alternative dietary strategy for weight-loss as IER 57 
entails intermittent periods of substantial energy restriction interspersed with periods of 58 
normal eating (4).  59 
 60 
Previous studies comparing the effects of IER to CER on cardiometabolic risk factors have 61 
found them to have equivalent effects on most metabolic outcomes (5-7). There is some 62 
suggestion that IER (two consecutive days of 70% ER) may elicit greater benefits than CER 63 
on proxies of hepatic insulin sensitivity (5, 6), however, no study to date has controlled for 64 
the extent of weight-loss; a confounding factor from the perspective of metabolic 65 
comparisons. In addition, the majority of studies have conducted steady-state assessments, 66 
with only fasting blood measurements taken which is not truly representative as humans 67 
spend most of their day in a postprandial state; a dynamic, non-steady state condition.  68 
Furthermore, impairments in postprandial glucose and lipid handling are widely regarded as 69 
clinically significant cardiovascular disease risk factors (8, 9) and as such must also be 70 
considered within metabolic comparisons. One uncontrolled study by Heilbronn et al (10) 71 
demonstrated a decline in glucose tolerance after three weeks of IER (alternate days of total 72 
ER) among healthy and overweight women. However, baseline and post-treatment 73 
postprandial assessments were conducted following 12 hour and 36 hour fasting periods 74 
respectively. Prolonged (36 hour) fasting intervals are known to impair glucose tolerance 75 
(11), and as such, the observed decline in glucose tolerance may not reflect a true chronic 76 
treatment effect. In sum, there is very little known about the effects of IER on postprandial 77 
metabolism.  78 
 79 
The present study, which was conducted as a randomised controlled dietary intervention in 80 
overweight/obese men and women, aimed to compare the effects of IER vs. CER on 81 
postprandial glucose and lipid responses to a liquid mixed test meal challenge following 82 
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matched 5% weight-loss. Changes in fasting cardiometabolic disease risk factors, resting 83 
energy expenditure (REE) and substrate oxidation were also assessed.  84 
Participants and methods  85 
Participants 86 
Overweight and obese participants (BMI > 25 kg/m2) aged 18-65 years were recruited to the 87 
study from Surrey (UK). All participants had an elevated waist circumference of >94 cm for 88 
men and >80 cm for women. Participants were weight-stable (±2 kg) over the preceding three 89 
months and had no significant medical history. To control for the potential influence of the 90 
menstrual cycle between visits, female participants were either post-menopausal (defined as 91 
absence of menses for ≥1 year) or taking oral contraceptives. The study obtained a favourable 92 
opinion from the University of Surrey ethics committee (UEC/2014/140/FHMS) and was 93 
conducted in accordance with the guidelines laid down in the Declaration of Helsinki. ISRCT 94 
registry number: ISRCTN13687043. The study ran between May 2015 and August 2016. 95 
 96 
Sample size considerations 97 
On the basis of our previous acute observations (11), changes in postprandial lipaemia was 98 
selected the primary outcome, with the a priori hypothesis that the relative improvement in 99 
lipaemia would be greater following weight-loss via IER. As no comparable study has been 100 
performed, comparting the effects of IER vs. CER following matched weight-loss, 101 
prospective power calculations were not possible. To assess the possibility of type two error, 102 
retrospective power calculations were conducted for a secondary outcome measure, 103 
postprandial glucose. For the iAUC for plasma glucose, retrospective power calculations 104 
determined that at a two-sided 0.05 significance level, the study had 80% power to detect a 105 
mean difference of 120 mmol.360min.L-1 between treatment groups (IER vs. CER), based on 106 
a pooled standard deviation of 105.0 mmol.360min.L-1.  107 
Study design  108 
The study was a randomised, parallel-armed, comparison between IER and CER. Participants 109 
were stratified by age (<42/≥42 years; mid-point of the recruitment range), BMI 110 
(<30/≥30kg/m2), gender, ethnicity and Homeostasis model assessment–insulin resistance 111 
(HOMA-IR;<1/≥1) to ensure balanced group allocation, with matched pairs randomly 112 
assigned 1:1 to the interventions. The CER intervention served as the “standard treatment” 113 
control, compliant with UK National Institute of Clinical Excellence (NICE) obesity 114 
guidelines (3).  115 
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 116 
To control for the degree of weight-loss, study measurements were taken at baseline and after 117 
participants had attained a 5% weight-loss, a threshold adjudged to have a clinically 118 
significant impact on cardiometabolic risk factors (12).  119 
 120 
Dietary interventions 121 
Estimated energy requirements were calculated using the Henry predictive equation (13) for 122 
basal metabolic rate multiplied by an appropriate physical activity factor based on self-123 
reported occupational and leisure activity levels (14). Healthy eating advice (compliant with 124 
UK guidelines) and individualised food portions lists were provided by an appropriately 125 
trained study investigator (RA). Participants were only informed of the comparison diet once 126 
they had completed the study.  127 
 128 
Intermittent energy restriction diet 129 
On two consecutive days of the week, participants consumed four commercially available 130 
LighterLifeTM very-low energy formula-based Food Packs (2638kJ: 38%, 36% and 26% of 131 
total energy as carbohydrate, protein and fat) which delivered ~25% of their estimated 132 
euenergetic needs. Consecutive days were chosen to mirror that of previously published work 133 
by Harvie et al (5,6). On the remaining five days (“feed days”), participants’ food intake was 134 
self-selected, but they were asked to consume an euenergetic healthy diet. Averaged overall 135 
prescribed ER was 22±0.3%. 136 
 137 
Continuous energy restriction diet 138 
Participants assigned to the CER diet were advised to consume a daily hypoenergetic diet of 139 
2510kJ below their estimated energy requirements (3). All foods were self-selected by 140 
participants. Averaged overall prescribed ER was 23±0.8%, comparable to the IER 141 
intervention. 142 
 143 
Laboratory visits 144 
All participants initially undertook a one-week baseline period during which time they were 145 
required to record habitual dietary intakes. At the end of this baseline, participants attended 146 
the Surrey Clinical Research Centre (Guildford, UK) for initial measurements. Participants 147 
were instructed to abstain from alcohol and strenuous exercise for 48 hours before the visit, 148 
and were provided with a standardised pasta-based microwaveable meal (2377kJ, 75g 149 
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carbohydrate, 16g fat, 24g protein), which they consumed before 20:00 on the preceding 150 
evening as the macronutrient composition of an evening meal can affect metabolic responses 151 
on the following day (15). Participants arrived at the research unit following a 12-hour 152 
overnight, water only fast. Body weight and body composition (estimated by multi-frequency 153 
bioimpedance) were recorded using (Tanita BC420MA; Tanita Corp, Tokyo, Japan) 154 
alongside measures of waist and hip circumference. After a period of rest, blood pressure 155 
measurements were taken in duplicate (UA-767; AND, San Jose, USA) and the mean 156 
recorded.  Following this, fasted resting measurements of energy expenditure and substrate 157 
utilisation were taken via indirect calorimetry. An indwelling cannula was then inserted 158 
following which the first (fasted) sample was taken. A liquid mixed test meal was provided 159 
(400ml Fortisip, Nutricia, Trowbridge, UK:  2510kJ, 74g carbohydrate [49% of total energy], 160 
24g protein [16%] and 23g fat [35%]) which participants consumed within 5 minutes. This 161 
homogenous liquid meal was used for the purpose of standardisation, to minimise potential 162 
variance in postprandial response associated with factors such as cooking/food preparation 163 
and chewing rate. In addition, its composition is reflective of the macronutrient proportions 164 
of typical western dietary intakes. Serial blood samples were taken at regular intervals over 165 
the next 360 minutes (from the first mouthful) to assess postprandial changes in glucose, 166 
insulin, C-peptide, triacylglycerol (TAG), non-esterified fatty acids (NEFA) and 3-167 
hydroxybutyrate (3-OHB). After the initial visit, both groups commenced their respective 168 
diets whilst maintaining habitual activity patterns. Participants returned to the research centre 169 
for repeated measurements once the 5% target was achieved. They consumed the same 170 
standardised evening meal and were given identical pre-visit instructions with regards to 171 
alcohol and exercise. Participants in both groups abstained from any form of ER for ≥7 days 172 
prior to the repeat study visit to mitigate the effects of acute ER on the metabolic outcomes. 173 
Participants did not complete diet diaries during this period however intake and weight were 174 
regularly reviewed during this period to ensure adherence.  175 
 176 
Monitoring and compliance 177 
Participants received fortnightly motivational contact from the study investigators via phone, 178 
email and/or texts in addition to monthly face-to-face clinic appointments, where weight was 179 
recorded. Every two weeks, participants were sent online questionnaires which asked them to 180 
self-report their morning fasted weight and, for IER participants, ER-day intakes with a 181 
compliant ER day defined as energy intake ≤3347kJ which corresponds to the very-low 182 
energy diet threshold defined by NICE (3). The frequency of weight monitoring increased as 183 
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participants approached their 5% target. All participants also completed seven-day diet 184 
diaries and self-reported physical activity levels mid-way (~ 2.5% weight-loss) and as they 185 
were approaching their 5% weight-loss target 186 
 187 
Blood biochemistry  188 
Blood samples were collected into potassium EDTA (for plasma lipid and insulin analysis) 189 
and sodium oxalate (for plasma glucose analysis). For the measurement of plasma C-peptide, 190 
blood was collected into EDTA containing 200 kallikrein inhibiting units of aprotinin per ml 191 
of whole blood. Samples were centrifuged for 15 minutes at 2500 rpm and separated; aliquots 192 
were then stored at -20°C or -80°C (for 3-OHB analysis). Plasma insulin was measured using 193 
radioimmunoassay (Millipore, Billerica, USA; intra/inter-assay CVs 8% and 4%); C-peptide 194 
by radioimmunoassay (Millipore; intra/inter-assay CVs 6% and 8%); glucose, TAG and 195 
NEFA using the ILAB 650 photometric auto-analyser (Instrumentation Laboratory, 196 
Warrington, UK; intra/inter-assay CV all <6 % and <6%); and 3-OHB using the Cobas 197 
MIRA photometric auto-analyser (Roche, Welwyn Garden City, UK; intra/inter-assay CVs 198 
<5% and <6%). All samples from an individual participant were included in the same assay. 199 
 200 
Indirect calorimetry  201 
REE and substrate utilisation were calculated using data obtained from a Gaseous Exchange 202 
Monitor ISGEM319 (GEM Nutrition, Cheshire, UK), an open-circuit indirect calorimeter 203 
based on the ventilated flow-through technique. Following a 30-minute period of rest, 204 
measurements were taken over 20 minutes and in accordance with methodological 205 
recommendations by Compher et al (16). REE was calculated utilising the modified Weir 206 
equation (17) and substrate utilisation implied from the respiratory quotient (RQ, VC02/VO2). 207 
To permit comparisons between individuals of varying body masses, REE was also 208 
normalised for estimated metabolically active mass (REE/fat free mass+18kg; (18)). 209 
 210 
Dietary analyses 211 
All dietary analyses were carried out in Diet Plan Seven (Forestfield Software, Horsham, 212 
UK) using the McCance and Widdowson’s composition of foods integrated dataset. 213 
Participants recorded food intake in validated diet diaries (19). Seven-day intakes were then 214 
averaged. Data for participants who did not complete a baseline seven-day food and/or at 215 
least one of their two diaries whilst dieting omitted completely from analyses. 216 
 217 
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Data manipulation and statistical analyses 218 
Area under the curve (AUC, for NEFA and 3-OHB) and incremental AUC (iAUC, for all 219 
other metabolites) were calculated using the linear trapezoid method, subtracting the area 220 
below baseline for iAUC. Low density lipoprotein (LDL)-cholesterol was calculated using 221 
the Friedewald equation (20). HOMA-IR and %B were calculated using the HOMA2 online 222 
calculator (https://www.dtu.ox.ac.uk/homacalculator/) as proxies for insulin sensitivity and β-223 
cell function respectively.  224 
 225 
Data were statistically analysed using SPSS v23 (IBM, Chicago, USA). Data were first 226 
checked for normality using the Shapiro-Wilks test, with non-normally distributed data 227 
normalised via log transformation where possible to permit parametric testing. The primary 228 
analysis was a one-factor analysis of covariance (ANCOVA) between the dietary intervention 229 
groups with post-treatment values as the dependent variable, and baseline values of each 230 
parameter as the covariate. This is recommended statistical method (in terms of bias, 231 
precision and power) for the analysis of continuous outcomes in randomised studies with a 232 
single post-treatment measurement previously measured at baseline (21). Between-group 233 
factors which could have influenced study outcomes (age, gender, body fat and metabolic 234 
syndrome status) were entered systematically into the outcome models, but none were found 235 
to be statistically significant. To then enter all of them at once into the models would have 236 
invited spurious results and thus these factors were not included as covariates in the final 237 
models. The Mann Whitney U test was used as the non-parametric alternative to ANCOVA. 238 
Differences between intervention groups at baseline were assessed using independent t-tests 239 
for continuous variables or the Chi squared test for categorical variables. No significant 240 
baseline differences were found unless otherwise stated. A paired t-test (or non-parametric 241 
Wilcoxon signed-rank test) was used to assess the change between baseline and post 242 
intervention values within each dietary intervention group. Correlations between changes in 243 
metabolic and dietary intake variables were explored using Pearsons (parametric) or 244 
Spearmans (non-parametric) tests as appropriate. Statistical significance was accepted at 245 
p<0.05, and a statistical trend at p=0.05-1.0. Summary measures are presented as mean±SEM 246 
(for parametric data) or median and interquartile range (IQR, for non-parametric data). 247 
 248 
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Results 249 
Participant baseline characteristics  250 
Seven participants allocated to the CER intervention did not start the study. Of the 41 251 
participants (IER=24, CER=17) who started the study, 27 (IER=15, CER=12) attained their 252 
5% weight-loss target. The consort diagram is presented in Figure 1.  253 
 254 
Baseline characteristics of the 27 study completers are presented in Table 1. The groups were 255 
matched for age, BMI, adiposity, gender, metabolic syndrome classification and were 256 
primarily Caucasian. Twelve participants withdrew from the study due to scheduling conflicts 257 
(IER=1), bereavement (IER=1), dental problems (IER=1), problems tolerating (IER=4) or 258 
adhering to (CER=2) their diet, or were lost to follow up (IER=2, CER=1). Two CER 259 
participants were unable to attain a 5% weight-loss within the maximum timeframe (nine 260 
months) and so were withdrawn from the study. Non-completers were significantly younger 261 
than completers (27±3 vs. 45±3 years; p<0.001, independent t-test), no other significant 262 
differences were noted. 263 
 264 
Changes in body composition and circumferences  265 
Mean percentage weight-loss was 5.3±0.3% in the IER group and 5.0±0.3% in the CER 266 
group (p=0.446, ANCOVA). The accompanying changes in body composition were also 267 
comparable between the groups (p≥0.430, ANCOVA) and are reported in Table 2. It took 268 
IER participants a median of 59 days (IQR: 41, 80) to attain their 5% weight-loss target and 269 
CER participants 73 days (IQR: 48, 128), which was not statistically different between 270 
groups (p=0.246, Mann Whitney U test).  271 
 272 
Dietary intakes and physical activity  273 
Changes in dietary intake are reported in Table 3. By the end of the intervention the 274 
reductions in energy intake were significantly greater in the IER group (mean difference: 275 
1081 kJ [95% confidence intervals: -1900, -263 kJ]; p=0.012 d=1.21, ANCOVA), with a 276 
similar tendency noted for total carbohydrate intake (mean difference: -28g [-57, 1 g]; 277 
p=0.054 d=0.90, ANCOVA). Adherence to the IER protocol (i.e. two substantial ER 278 
days/week) was high (93±4%), and were most frequently completed on consecutive days 279 
(86±7%). Physical activity levels remained stable in both groups across the study. 280 
 281 
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Fasting biochemistry and physiological markers 282 
Changes in fasting biochemistry and physiological markers are reported in Table 4.  283 
 284 
There were no significant between-group differences for changes in all fasting biochemical 285 
measures (all p≥0.147, ANCOVA). Within the IER group, there was a small increase in 286 
fasting glucose (p=0.008, paired t-test) post weight-loss, whilst a trend in favour of reduced 287 
plasma NEFA was also found (p=0.056, paired t-test).  288 
 289 
The IER group exhibited a significantly greater reduction in systolic blood pressure (mean 290 
difference [95% confidence intervals]: -6 mmHg [-11, -1 mmHg]; p=0.020 d=1.17, 291 
ANCOVA), whereas the decreases in diastolic blood pressure were comparable between 292 
groups (p=0.691, ANCOVA). A positive relationship between the changes in energy intake 293 
and systolic blood pressure was found (r=0.461, p=0.047). 294 
 295 
There were no significant differences between-groups for changes in REE (p=0.205, 296 
ANCOVA), although a trend in favour of a reduction was observed following IER (p=0.058, 297 
paired t-test). Similar within-group trends were noted when REE was normalised for 298 
metabolically active mass, whereas the between-group differences were strengthened (mean 299 
difference [95% confidence intervals]: -7.28 kJ/kg MAM/day [-15.07, 0.510 kJ/kg 300 
MAM/day; p=0.067 d=0.97, ANCOVA).  301 
 302 
The relative change in RQ was not significantly different between the two diets (p=0.148, 303 
Mann Whitney U test) although a significant within-group decline in fasting RQ was noted in 304 
the IER group (p=0.045, Wilcoxon signed ranks test). 305 
 306 
Postprandial lipid metabolism 307 
Postprandial lipid parameters before and after the dietary interventions are presented in 308 
Figure 2, and as averaged hourly iAUC in Supplementary Figure 1. The relative reduction 309 
in postprandial TAG was significantly greater following IER vs. CER (p=0.045 d=0.83, 310 
ANCOVA). The log transformed mean difference between groups was -0.112  311 
mmol.360min.L-1 [-0.221, -0.003  mmol.360min.L-1]. A trend in favour of a positive 312 
relationship between decreases in incremental TAG and RQ was found (r=0.34, p=0.06). For 313 
postprandial NEFA, there were no significant between-group differences (p=0.410, Mann-314 
Whitney U test), although, a tendency for reduced NEFA AUC was observed within the CER 315 
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group (p=0.059, Wilcoxon signed ranks test). No significant within-group changes (p=0.618, 316 
ANCOVA) or between-group differences (p≥0.248, paired t-tests) in postprandial 3-OHB 317 
responses were found.  318 
Postprandial glucose metabolism 319 
Postprandial glycaemic indices before and after the dietary interventions are presented in 320 
Figure 3. For postprandial glucose responses, no significant between-group differences 321 
(p=0.226, ANCOVA) or within-group changes were observed. Postprandial insulinaemia was 322 
reduced comparatively in both groups (p=0.903, ANCOVA). On the other hand, postprandial 323 
c-peptide was reduced following IER but not CER (p=0.057 trend d=0.81, ANCOVA), with a 324 
mean difference (95% confidence intervals) between groups of -61769 pmol.360min.L-1 [-325 
127496, 3957 pmol.360min.L-1].326 
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Discussion 327 
Findings from the present study highlight underlying differences between IER and CER with 328 
respect to their effects on postprandial glucose and lipid metabolism following matched 5% 329 
weight-loss. These data are novel and as such, there are no directly comparative data in the 330 
literature. 331 
 332 
In our previous work we have reported that acutely, one day of substantial 75% ER reduced 333 
incremental TAG responses by ~60% (11). Chronically, the present study found a ~40% 334 
reduction in incremental responses following 5% weight-loss achieved through IER. This 335 
finding has the potential to be of clinical importance based on evidence from large 336 
prospective cohort studies highlights an independent link between elevated postprandial TAG 337 
and CVD risk (22-24). Moreover, postprandial TAG responses has also been shown to 338 
predict the presence of coronary artery disease with one study in adult males finding that the 339 
magnitude of lipaemia was ~41% greater among cases versus controls (25), and has been 340 
positively correlated with markers of atherosclerotic progression (26). The mechanisms 341 
underlying these associations include the direct interaction between TAG-rich lipoprotein 342 
(TRL) remnants and the arterial wall, as well as indirect mechanisms, such as alterations in 343 
LDL particle size (27). There is  344 
 345 
Postprandial assessments were limited to measuring changes in absolute substrate 346 
concentrations after a single meal, and which represent the balance but not the rate (or 347 
source) of TRL appearance or clearance, and as such their relative contributions cannot be 348 
ascertained. There were no significant differences between the dietary groups in changes in 349 
postprandial hepatic fatty acid partitioning (3-OHB) or NEFA which might have otherwise 350 
explained these findings. Reductions in waist circumference were also comparable between 351 
groups, but this cannot differentiate between changes in intra-hepatocellular or visceral stores 352 
which can augment postprandial lipaemia by driving increased very low density lipoprotein–353 
TAG production (28, 29). Interestingly, a within-group increase in whole-body fat oxidation 354 
was observed following IER but not CER in the present study, although not statistically 355 
different between groups. It is perhaps not unreasonable to speculate that the repeated 356 
substantive periods of ER experienced during IER may have upregulated pathways associated 357 
with fatty acid metabolism and uptake in skeletal muscle and/or adipose tissues, manifesting 358 
as changes in basal substrate oxidation and postprandial lipaemia. These preliminary results 359 
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justify more detailed investigations into the kinetics of TAG metabolism, using targeted 360 
methodology. 361 
Although insulin responses to the meal challenge were reduced comparatively following 362 
weight-loss via both IER and CER, however, using concurrent measurements of both insulin 363 
and C-peptide, the study does propose differences between the two weight-loss diets in terms 364 
of underlying mechanism. C-peptide undergoes negligible extraction by the liver and constant 365 
peripheral clearance, thus making it a more direct marker of insulin secretion than circulating 366 
insulin (30). Following CER, insulinaemia was reduced whereas postprandial C-peptide was 367 
unaltered, which suggest an increase in hepatic insulin clearance. By contrast, postprandial C-368 
peptide responses following IER may reveal reduced insulin secretion over the first two hours 369 
of the six-hour postprandial period. Although this did not ultimately result in a significant 370 
alteration in glucose tolerance, the underlying mechanism and biological significance merits 371 
further evaluation. 372 
 373 
At baseline, approximately half of IER participants were either pre-hypertensive (120-374 
139/80-89 mmHg) or hypertensive (>140–159/90–99 mmHg). Following weight-loss, all but 375 
one IER participants became normotensive (<120/80 mmHg). In contrast, the proportion of 376 
participants who were pre- or hypertensive (~30%) did not change significantly following the 377 
CER diet. The shift observed in the IER group was largely driven by a reduction in systolic 378 
blood pressure, which was not significantly altered by CER. A positive relationship was 379 
found between the magnitude of the reduction in systolic blood pressure and the degree of 380 
ER, which as discussed in the next paragraph was greater in the IER group. It should be noted 381 
that the numerical trends in favour of higher baseline systolic blood pressures within the IER 382 
group would have been adjusted for by the ANCOVA statistical method. To date, previously 383 
published comparison studies have found no significant differences between the two diets (5-384 
7); thus,  these findings are unexpected and necessitate replication before any conclusions can 385 
be drawn and to exclude the possibility of type one error.  386 
 387 
The time taken to achieve 5% weight-loss was not statistically different between groups, 388 
although, the IER group reported greater relative reductions in energy (~1081 kJ/day) driven 389 
by under-consumption on “feed” days (where an euenergetic diet was prescribed), which is in 390 
accordance with previous research (5-7). Numerically, IER participants attained their weight-391 
loss target sooner (median 59 vs 73 days). Although type two error cannot be disregarded, on 392 
the alternate side of the energy balance equation, absolute REE was reduced by ~7% (~477 393 
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kJ) following IER, but not CER which may have contributed to these discrepancies between 394 
the dietary intake data and weight-loss trajectories. Food dietary records are susceptible to 395 
under-reporting (31), but this would have affected the validity of dietary records of both 396 
groups. These data may also be indicative of subtle alterations in physical activity 397 
thermogenesis which could not be captured by the factorial approach implemented by the 398 
study. Changes in body composition were comparable between groups, however, when 399 
normalised for metabolically active mass, the between-group differences in REE became 400 
more pronounced. In the context of the existing literature, our data contrast with Cattenaci’s 401 
recent study (32) which found that weight-loss via IER (alternating days of total ER and ad 402 
libitum intake) mitigated the adaptive physiological reductions in REE that occur during 403 
weight-loss. However, the varying dietary protocols do not permit direct comparisons 404 
between studies, with one important distinction here being that participants under-consumed 405 
on “feed” days so most probably rarely attained energy balance. 406 
 407 
There were some important caveats with IER, in that a higher attrition rate was reported 408 
among participants who started the intervention. Overall dropout rates were 34% in the study 409 
cohort as a whole, which exceeds that of previous studies utilising analogous 2-ER days per 410 
week protocols where rates have ranged from 21-23% (5, 6). This discrepancy can largely be 411 
attributed to the study design, whereby participants were assigned to the diet until a weight-412 
loss target was achieved rather than fixed duration of time. More recently, a study by 413 
Trepanowski et al (7) of alternate day ER also reported a higher attrition rate among IER 414 
participants of 38% vs. 29% among CER participants. Put together, data from ours and 415 
Trepanowski’s study do not support the popular notion that IER could prove “easier” to 416 
follow than CER, warranting further investigation of the factors that can influence the 417 
acceptability of IER amongst the public. Among the 24 participants assigned to the CER 418 
intervention, only 17 started with the majority (71%) declining to participate or contact was 419 
lost. Participants were blinded to the comparison diet which suggests that there was no bias to 420 
the IER diet per se, but, the perceived lack of novelty may have contributed to the drop outs 421 
in the CER group prior to commencing the diet. 422 
 423 
The main strengths of the study were that weight-loss as an independent metabolic 424 
confounder, was controlled for, and the study conducted dynamic, concurrent, assessments of 425 
postprandial glucose and lipid metabolism in addition to static, steady-state measurements. 426 
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Limitations include the small sample of both overweight and obese participants which can 427 
increase the risk of type one and two error, use of bioimpedance, and that postprandial 428 
assessments were only conducted following a single meal. Correlation analyses found no 429 
relationship between the degree of ER to the degree of change in most outcome measures 430 
(with the exception of systolic blood pressure). It should be noted that the absence of a 431 
statistical relationship does not rule out the absence of a potential effect influenced by the 432 
greater overall ER during IER to study findings. Lastly, physical activity levels were only 433 
assessed via the factorial method, which is insensitive to small changes in activity and is 434 
unable to differentiate between the various components of energy expenditure. 435 
 436 
In summary, our preliminary data suggests that mode of ER (intermittent but severe vs. 437 
modest continuous) may have different cardiometabolic effects in which may be important to 438 
long-term disease risk. Differences were observed between the diets, particularly with regards 439 
to postprandial lipaemia which was reduced to a greater extent following IER. In addition, 440 
these data also reveal distinctions between IER and CER with regards to their effects on 441 
insulin secretion dynamics, REE and blood pressure. These data now warrant further 442 
investigation utilising targeted methodology, and within distinct population groups such as 443 
individuals with morbid obesity and established metabolic disorders. Future studies should 444 
implement rigorous controls over energy intake and expenditure to minimise the influence 445 
that variances in these factors might have on study outcomes.  446 
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 IER  
(n=15) 
CER  
(n=12) 
IER vs  
CER 
Age (years)  42 sem 4 48 sem 3 0.289 
Gender (M/F)  7 / 8 6 / 6 0.863 
Ethnicity 
Caucasian  
Black African 
  
15 
0 
 
11 
1 
0.255 
BMI (kg/m2)  29.8 sem 0.9 30.8 sem 1.1 0.482 
Overweight/obese  9/6 6/6 0.707 
Body fat (%)1  34.8 sem 2.2 37.5 sem 2.0 0.385 
Metabolic Syndrome2  4 / 15 2 / 12 0.535 
 556 
Table 1 Baseline characteristics for study completers  557 
1 Bioimpedance. 2 International Diabetes Federation criteria. 558 
Statistics and data presentation: Between group comparisons conducted using unpaired t-test 559 
or Chi squared (for ethnicity, metabolic syndrome). Presented as mean ± SEM. 560 
Abbreviations: CER – Continuous energy restriction; IER – Intermittent energy restriction; 561 
NS – Non-significant.  562 
  563 
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 564 
 
IER 
(n=15) 
CER 
(n=12) 
 
 Baseline Post Baseline Post 
IER vs 
CER 
 Mean SEM Mean SEM Mean SEM Mean SEM  
Weight (kg) 88.8 3.4 84.1 3.2a 89.3 4.5 84.9 4.3a 0.430 
Fat mass (kg) 30.8 2.3 27.1 2.3a 33.8 2.9 30.0 2.7a 0.821 
Fat free mass (kg) 58.0 3.1 57.0 3.0a 55.5 2.6 54.8 2.8a 0.437 
Waist (cm) 102 3.0 98 2.0a 102 2.0 97 2.0a 0.489 
Hip (cm) 113 2.0 109 2.0a 115 3.0 110 2.0a 0.876 
 565 
Table 2 Body composition before and after 5% weight-loss via IER and CER 566 
Abbreviations: IER, Intermittent energy restriction; CER, Continuous energy restriction; NS, 567 
Non-significant.  568 
Statistics and data presentation: Between group comparisons conducted using analysis of 569 
covariance. a Significant within-group change (p<0.05, paired t-test). Presented as mean ± 570 
SEM.  571 
  572 
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Table 3 Dietary intakes and physical activity levels at baseline, midway through (2.5% weight-loss) and at the end (nearing 5% weight 
loss) of the IER and CER dietary interventions.  
Abbreviations: IER, Intermittent energy restriction; CER, Continuous energy restriction; NS, Not significant. 
Statistics and data presentation: Between group comparisons conducted using analysis of covariance. a-b Significant within-group change: a vs 
baseline or b between mid-way vs end time-points (p<0.05, paired t-test). (a-b) Within-group trend (p=0.05-0.1). Presented as mean ± SEM of 
seven days or five feed days.
 IER CER  
 
Baseline  
(n=12) 
Midway  
(n=8) 
End  
(n=12) 
Baseline 
(n=11) 
Midway  
(n=6) 
End  
(n=11) 
IER vs 
CER 
 Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM  
Energy intake (kJ/day) 8057 432 5771 358a 5199 319a 8437 594 6423 421a 6396 300a 0.012 
Feed days only - - 7077 479 6236 447a - - - - -   
Carbohydrate (g/day) 224 20 147 10a 141  9a 258  38 177 16(a) 175 12a 0.054 
- Feed days only - - 183 13 170 14a - - - - - - 
Fibre (g/day) 19 1 18 1 19 2 19 1 18 2 18 1 0.590 
Feed days only - - 19 2 18 1 - - - - - - - 
Sugars (g/day) 84 14 48  8a 52 8a 91 12 61 10(a) 66  8a 0.259 
Feed days only - - 62 11 62  11(a) - - - - - - - 
Fat (g/day) 74 5 52 5a 45 15a 82 6 54 2a(b) 57  4a(b) 0.110 
Feed days only - - 66  9a 56  6a - - - - - - - 
Saturated fat (g/day) 29 3 19 2a 16 2a 30 3 17 1a(b) 19  1a(b) 0.206 
Feed days only - - 25 4 20  3(a) - - -  - - - 
Protein (g/day) 83 5 73 3a 67  5a 80 5 80 7 69  7(a) 0.523 
Feed days only - - 78 4a 63 7a - - - - - - - 
Alcohol (g/day) 10 3 8  4a 11  5a 11 3 8 2 7  2a 0.659 
Salt (g/day) 5.4 0.6 4.9 0.5 4.0 1.3 5.5 0.5 5.5 1.0 3.8  0.2a 0.544 
Feed days only - - 4.4  0.5a 3.6  0.3a - - - - - - - 
Carbohydrate (% total energy) 43 2 40 2 42  2 42 2 43 1 42 2 0.830 
Feed days only - - 40 2 43 2 - - - - - - - 
Fat (% total energy) 34 1 33 2 32 1 36 1 32 2a 33 2 0.872 
Feed days only - - 35 3 33 2 - 1 - - - - - 
Protein (% total energy) 18 1 21  2(a) 22 1a 16 1 20 1 19  1(a) 0.302 
Feed days only - - 19 2 19 2 - - - - - - - 
Alcohol (% total energy) 4 1 4 1 2 1 4 1 3 1 3 1 0.326 
Physical activity levels  1.56 0.02 1.57 0.01 1.57 0.01 1.54 0.01 1.54 0.01 1.54 0.01 0.885 
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Table 4 Fasting biochemistry and physiological markers before and after 5% weight-loss via IER and CER 
Abbreviations: IER, Intermittent energy restriction; CER, Continuous energy restriction; NS, Not significant; HOMA, Homeostasis model 
assessment; IR, Insulin resistance; TOTC, Total cholesterol; LDL, Low density lipoprotein; HDL, High density lipoprotein; TAG, 
Triacylglycerol; NEFA, Non-esterified fatty acids; 3-OHB, 3-hydroxybutyrate; BP, blood pressure; REE, Resting energy expenditure; MAM, 
Metabolically active mass; RQ, Respiratory quotient. 
Statistics and data presentation: Between group comparisons conducted using analysis of covariance (parametric) or Mann Whitney U test (non-
parametric). a Significant within-group change (p<0.05, paired t-test or Wilcoxon signed ranks). (a) Within-group trend  
(p=0.05-0.1). Presented as mean ± SEM or as median [interquartile range, IQR]. *n=24 (IER=13, CER=11. † n=23 (IER=13, CER=10). 
 IER (n=14) CER (n=12)  
 Baseline Post Baseline Post  
 
Mean/ 
median 
SEM/ 
[IQR] 
Mean/ 
median 
SEM/ 
[IQR] 
Mean/ 
median 
SEM/ 
[IQR] 
Mean/ 
median 
SEM/ 
[IQR] 
IER vs CER 
Glucose (mmol/L) 4.4 0.1 4.6 0.1a 4.4 0.2 4.4 0.2 0.158 
Insulin (pmol/l) 78 8 71 5 64 8 59 7 0.324 
C-Peptide (pmol/l) 527 36 504 38 504 45 475 35 0.818 
HOMA-IR 1.6 0.2 1.5 0.1 1.3 0.1 1.2 0.1 0.282 
HOMA-%B 139 10 126 8 138 12 130 8 0.676 
TOTC (mmol/L) 4.2 0.3 4.0 0.2 4.2 0.3 4.0 0.3 0.948 
LDL (mmol/L) 2.6 0.3 2.4 0.2 2.7 0.2 2.6 0.2 0.837 
HDL (mmol/L) 1.1 0.1 1.1 0.1 1.0 0.1 1.0 0.1 0.723 
TAG (mmol/L) 1.1 0.1 1.0 0.1 0.9  0.1 0.8 0.1 0.147 
NEFA (µmol/L)* 637 63 491  50(a) 517 56 536 70 0.454 
3-OHB (µmol/L)* 144 37 112  33 84 19 115 33 0.351 
Systolic BP (mm/Hg) 123 3 111  3a 115 3 113 3 0.020 
Diastolic BP (mm/Hg) 74 3 69  3(a) 75 3 70 4a 0.691 
REE (kJ/day) † 6617 257 6139 256(a) 6190 309 6259 332 0.205 
REE (kJ/kg MAM/day)† 87 4 81  2(a) 83 2 85 2 0.067 
RQ (VC02/VO2)† 0.86 [0.84,0.88] 0.83 [0.77,0.89]a 0.87 [0.84,0.9] 0.86 [0.83,0.90] 0.148 
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Legends for figures 
Figure 1: Consort diagram. NB: Matched pairs could not be found for two participants to 
ensure balanced group allocation and so these individuals were not randomised to an 
intervention. 
 
Figure 2 A-I Postprandial lipid indices before and after 5% weight-loss via IER and 
CER 
IER (filled circles), CER (filled squares). For postprandial graphs: Baseline (black) and post-
treatment (grey). Liquid test meal provided: 2510kJ, 74g carbohydrate, 24g protein and 23g 
fat.  
Abbreviations: AUC, Area under the curve; CER, Continuous energy restriction; iAUC, 
Incremental area under curve; IER, Intermittent energy restriction; NEFA, non-esterified fatty 
acids; 3-OHB, 3-hydroxybutyrate.  
Statistics and data presentation: 1Paired t-tests or 2Wilcoxon signed ranks test. 3Analysis of 
covariance or 4Mann Whitney U test. Figure 2F presented as median (interquartile range), all 
other data as mean ± SEM. TAG: n=26 (IER=14, CER=12). NEFA and 3-OHB: n=24 
(IER=13, CER=11). 
 
Figure 3 A-I) Postprandial glycaemic indices before and after 5% weight-loss via IER 
and CER 
IER (filled circles), CER (filled squares). For postprandial graphs: Baseline (black) and post-
treatment (grey). Liquid test meal provided: 2510kJ, 74g carbohydrate, 24g protein and 23g 
fat.  
Abbreviations: AUC, Area under the curve; CER, Continuous energy restriction; IER, 
Intermittent energy restriction; iAUC, Incremental area under curve. 
Statistics and data presentation: 1Paired t-tests. 2Analysis of covariance. Presented as mean ± 
SEM. n=26 (IER=14, CER=12). 
